HomeAnswersMedical oncologyrenal cancer

Is Sunitinib the only option for papillary RCC type 1?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

My father was recently diagnosed with papillary renal cell carcinoma type 1, and he has no BP or sugar. However, he had undergone bypass surgery ten years ago. Our doctor has suggested that targeted therapy is better for him, as there is another mass found in the lungs, too. Our doctor has prescribed Sutent 37.5 mg to begin with and slowly increase it to 50 mg.

However, due to our financial conditions, we cannot afford Sutent as it is pretty expensive for us. As we do not have any insurance. Is this the only drug available for this type of cancer, or do we have any other affordable and similar drugs with minimal side effects? We want to get your suggestion on this.

Kindly help.

Answered by Dr. Pawar Satyajit Jalinder

Education:

MBBS

Professional Bio:

Dr. Pawar Satyajit Jalinder is a dedicated medical oncologist with expertise in the diagnosis and treatment of a wide range of solid tumors and hematological malignancies. He has experience managing complex cancer cases and is certified in the treatment of various cancers using evidence-based and personalized approaches. In addition to oncology, Dr. Pawar Satyajit Jalinder has experience managing complicated multisystem rheumatological disorders and infections. He has contributed to medical research with publications on tuberculosis and cancers such as multiple myeloma, lung cancer, and sarcomas. Dr. Pawar Satyajit Jalinder is committed to delivering compassionate, patient-centered care while helping patients make informed treatment decisions.

This doctor is not available for online consultations on the platform anymore.

Hello,

Welcome to icliniq.com.

As per the history given above, your father has metastatic renal cell carcinoma. I would have liked to have a few additional markers, like his general condition, report of CBC (complete blood count) and LFT (liver function test), RFT (renal function test), to look at his risk score. In metastatic RCC, in first-line settings, we have three TKIs (Tyrosine kinase inhibitors) that are approved and commonly used. Namely, Sunitinib, Pazopanib, and Cabozantinib.

Sunitinib and pazopanib have almost the same progression-free survival benefit. Cabozantinib has a benefit in progression, but final overall survival was the same as Sunitinib. Toxicities are a bit different for Pazopanib, with more chances of hepatitis, weight loss, and diarrhea.

If you cannot afford Sunitinib, then I would say Pazopanib would be better as it is cheaper with similar benefits and slightly different toxicities. Cabozantinib is costlier and not yet available. I hope it helps. I would be happy to help you further if you have any more queries or questions regarding the toxicities of these drugs.

I hope this helps.

Thank you.

Medically reviewed by Dr. Nithila. A
Published At June 24, 2019
Reviewed At December 24, 2025

Education:

MBBS

Professional Bio:

Dr. Pawar Satyajit Jalinder is a dedicated medical oncologist with expertise in the diagnosis and treatment of a wide range of solid tumors and hematological malignancies. He has experience managing complex cancer cases and is certified in the treatment of various cancers using evidence-based and personalized approaches. In addition to oncology, Dr. Pawar Satyajit Jalinder has experience managing complicated multisystem rheumatological disorders and infections. He has contributed to medical research with publications on tuberculosis and cancers such as multiple myeloma, lung cancer, and sarcomas. Dr. Pawar Satyajit Jalinder is committed to delivering compassionate, patient-centered care while helping patients make informed treatment decisions.

This doctor is not available for online consultations on the platform anymore.

Education:

BDS

Professional Bio:

Dr. Nithila A is a Dental Surgeon specializing in providing comprehensive oral healthcare. She focuses on preventive care, routine dental treatments, and patient education to maintain optimal oral health. Known for her compassionate and patient-centered approach, she ensures comfortable and effective dental care tailored to the individual needs of each patient.

This doctor is not available for online consultations on the platform anymore.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Education:

MBBS

Professional Bio:

Dr. Pawar Satyajit Jalinder is a dedicated medical oncologist with expertise in the diagnosis and treatment of a wide range of solid tumors and hematological malignancies. He has experience managing complex cancer cases and is certified in the treatment of various cancers using evidence-based and personalized approaches. In addition to oncology, Dr. Pawar Satyajit Jalinder has experience managing complicated multisystem rheumatological disorders and infections. He has contributed to medical research with publications on tuberculosis and cancers such as multiple myeloma, lung cancer, and sarcomas. Dr. Pawar Satyajit Jalinder is committed to delivering compassionate, patient-centered care while helping patients make informed treatment decisions.

This doctor is not available for online consultations on the platform anymore.

Listen to related tracks in our music library
Comprehensive Second Opinion

Read answers about:

renal cancer

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.